a trial was performed on thirty-two patients with cerebrovascular disease ( transient ischaemic attack and stroke ) to assess the effect of ticlopidine , a new inhibitor of platelet aggregation , on some platelet functions and coagulation , and its safety in long-term use ( 6 months ) .
C0038454
stroke
C0040207
ticlopidine